🔎 Trials Near Me

Dachaigh › Leukemia myeloid geur › New Jersey › Clifton

Sgrùdaidhean clionaigeach Leukemia myeloid geur ann an Clifton, NJ

Tha 12 sgrùdaidhean airson Leukemia myeloid geur a’ lorg phàirtichean aig làraichean ann agus timcheall air Clifton (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

A’ fastadhÌre 1
  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mìle air falbh
Aoisean 12 gu 78 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT03802695

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

A’ fastadhÌre 3
  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06852222

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

A’ fastadhÌre 3
  • Hackensack University Medical Center, Hackensack · 7 mìle air falbh
6 Months – 21 Years · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT04293562

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

A’ fastadhÌre 2
  • John Theurer Cancer Center at Hackensack UMC, Hackensack · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT06824168

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

A’ fastadhÌre 3
  • Hackensack University Medical Center, HMH, Hackensack · 7 mìle air falbh
29 Days – 21 Years · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT05183035

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

A’ fastadhÌre 1
  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT06001788

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

A’ fastadhÌre 2
  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

A’ fastadhSgrùdadh amharc
  • Hackensack University Medical Center, Hackensack · 7 mìle air falbh
Gach aois · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT01351545

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

A’ fastadhÌre 2/3
  • John Theurer Cancer Center / Hackensack University, Hackensack · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Gibl 2026 · NCT04256317

Phase IB/II of CPX-351 for Relapse Prevention in AML

A’ fastadhÌre 1/2
  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Màrt 2026 · NCT04990102

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

A’ fastadhÌre 1
  • Hackensack University Medical Center, Hackensack · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Màrt 2026 · NCT05735184

Sgrùdaidhean Leukemia myeloid geur ann am bailtean eile

Sgrùdaidhean eile ann an Clifton

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.